Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

JPMorgan Chase & Co. (JPM) delivered earnings and revenue surprises of 9.74% and 4.82%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

PLIANT THERAPT (PLRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks.com users have recently been watching Super Micro (SMCI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Gorilla Technology Group Inc. GRRR recently announced 2024 adjusted EPS of $2.02, significantly outperforming the Zacks Consensus Estimate and increasing from the year-ago level. Total revenues grew ...